{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:17:30Z","timestamp":1783401450133,"version":"3.54.6"},"reference-count":33,"publisher":"Georg Thieme Verlag KG","issue":"CP","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endosc Int Open"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pancreatic ductal adenocarcinoma (PDAC) is a poor prognostic malignancy. Comprehensive genomic profiling (CGP) has improved outcomes in many cancers, but widespread uptake in PDAC remains elusive. This study investigated the feasibility of using endoscopic ultrasound with fine-needle biopsy (EUS-FNB) for CGP in advanced PDAC.<\/jats:p>\n                  <jats:p>A multicenter prospective cohort study was conducted to assess the feasibility of using DNA and RNA extracted from fresh frozen or archival formalin-fixed paraffin-embedded (FFPE) EUS-FNB for CGP on advanced PDAC using the TSO-500 gene panel testing. Results of the CGP were reviewed at a molecular tumor board (MTB) and subsequent treatment recommendations were forwarded to the referring clinicians.<\/jats:p>\n                  <jats:p>CGP was successful in 129 of 143 patients (90%) enrolled between May 2020 to September 2023. Fresh frozen EUS-FNB provided suitable genetic material for CGP in 123 of 133 patients (92%). Conversely, CGP was successful on FFPE biopsy blocks from only six of 16 patients (38%). Fifty-two of 143 patients (36%) had a potentially targetable mutation detected, and eight of these patients (6%) were treated with targeted therapy based on their EUS-FNB-derived molecular profile. Patients who received personalized therapy had a significant (P &lt; 0.0001) increase in survival versus standard or no therapy at 12 and 36 months. Median patient survival on standard therapy was 9.47 months versus &gt; 18 months for personalized therapy.<\/jats:p>\n                  <jats:p>This real-world study confirms the feasibility and utility of CGP using EUS-FNB in advanced PDAC. It illustrates the importance of timely access to personalized therapy informed by CGP, which can impact the treatment pathway and improve survival outcomes.<\/jats:p>","DOI":"10.1055\/a-2733-1068","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:48:02Z","timestamp":1761608882000},"source":"Crossref","is-referenced-by-count":1,"special_numbering":"S","title":["Endoscopic ultrasound molecular evaluation of pancreatic cancer trial to profile molecular landscape of inoperable pancreatic ductal adenocarcinoma"],"prefix":"10.1055","volume":"14","clinical-trial-number":[{"clinical-trial-number":"actrn12620000762954","registry":"10.18810\/anzctr"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8280-216X","authenticated-orcid":false,"given":"Owen","family":"McKay","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology, Monash Health, Melbourne, Australia"},{"name":"Upper Gastrointestinal Surgery, Monash Health, Clayton, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Lundy","sequence":"additional","affiliation":[{"name":"Medical Oncology, Peninsula Health, Frankston, Australia"},{"name":"Upper Gastrointestinal Surgery, Monash Health, Clayton, Australia"},{"name":"Cancer and Immune Signalling, Hudson Institute of Medical Research, Clayton, Australia"},{"name":"Faculty of Medicine, Nursing and Health Sciences, Department of Surgery, Monash University, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Bell","sequence":"additional","affiliation":[{"name":"Gastroenterology and Hepatology, Monash Health, Melbourne, Australia"},{"name":"Faculty of Medicine, Nursing and Health Sciences, Department of Surgery, Monash University, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil","family":"Ha","sequence":"additional","affiliation":[{"name":"Gastroenterology & Hepatology, Peninsula Health, Frankston, Australia"},{"name":"Gastroenterology and Hepatology, Monash Health, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Gao","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Nursing and Health Sciences, Department of Surgery, Monash University, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Jenkins","sequence":"additional","affiliation":[{"name":"South Australian ImmunoGENomics Cancer Institute (SAiGENCI), Adelaide University, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chamkaushalya","family":"Bulathsinghalage","sequence":"additional","affiliation":[{"name":"Upper Gastrointestinal Surgery, Monash Health, Clayton, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Swan","sequence":"additional","affiliation":[{"name":"Gastroenterology & Hepatology, Monash Health, Clayton, Australia"},{"name":"Faculty of Medicine, Nursing and Health Sciences, Department of Surgery, Monash University, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Hew","sequence":"additional","affiliation":[{"name":"Gastroenterology & Hepatology, Monash Health, Clayton, Australia"},{"name":"Faculty of Medicine, Nursing and Health Sciences, Department of Surgery, Monash University, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Lee","sequence":"additional","affiliation":[{"name":"Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia"},{"name":"Medical Oncology, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranav","family":"Dorwal","sequence":"additional","affiliation":[{"name":"Genomics & Anatomical Pathology, Monash Health, Clayton, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoop S","family":"Bhutani","sequence":"additional","affiliation":[{"name":"Gastroenterology, University of Texas MD Anderson Cancer Center, Houston, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Rathi","sequence":"additional","affiliation":[{"name":"Genomics & Anatomical Pathology and Lifestrands Genomics Australia, Monash Health, Clayton, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Grimmond","sequence":"additional","affiliation":[{"name":"Collaborative Centre for Genomic Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Perry","sequence":"additional","affiliation":[{"name":"Monash Genomics & Bioinformatics Platform, Monash University, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Wilson","sequence":"additional","affiliation":[{"name":"Hudson Genomics Facility, Hudson Institute of Medical Research, Clayton, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Strickland","sequence":"additional","affiliation":[{"name":"Medical Oncology, Monash Health, Clayton, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Zalcberg","sequence":"additional","affiliation":[{"name":"Medical Oncology, Alfred Health, Melbourne, Australia"},{"name":"Nursing and Health Sciences, Public Health, Faculty of Medicine, Monash University, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Croagh","sequence":"additional","affiliation":[{"name":"Upper Gastrointestinal Surgery, Monash Health, Clayton, Australia"},{"name":"Cancer and Immune Signalling, Hudson Institute of Medical Research, Clayton, Australia"},{"name":"Faculty of Medicine, Nursing and Health Sciences, Department of Surgery, Monash University, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.4708","article-title":"Estimated projection of US cancer incidence and death to 2040","volume":"4","author":"L Rahib","year":"2021","journal-title":"JAMA Netw Open"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3390\/jcm8081173","article-title":"New era of endoscopic ultrasound-guided tissue acquisition: Next-generation sequencing by endoscopic ultrasound-guided sampling for pancreatic cancer","volume":"8","author":"H Imaoka","year":"2019","journal-title":"J Clin Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/17562848231171456","article-title":"The role of molecular testing in pancreatic cancer","volume":"16","author":"DB Zhen","year":"2023","journal-title":"Ther Adv Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"603","DOI":"10.6004\/jnccn.2019.5007","article-title":"NCCN Guidelines Updates: Pancreatic Cancer","volume":"17","author":"MA Tempero","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.annonc.2023.08.009","article-title":"Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"T Conroy","year":"2023","journal-title":"Ann Oncol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1200\/JCO.20.01364","article-title":"Metastatic Pancreatic Cancer: ASCO Guideline Update","volume":"38","author":"DPS Sohal","year":"2020","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.770022","article-title":"EUS-FNA biopsies to guide precision medicine in pancreatic cancer: Results of a pilot study to identify KRAS wild-type tumours for targeted therapy","volume":"11","author":"J Lundy","year":"2021","journal-title":"Front Oncol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"354","DOI":"10.5694\/mja18.00227","article-title":"Cancer Molecular Screening and Therapeutics (MoST): a framework for multiple, parallel signal-seeking studies of targeted therapies for rare and neglected cancers","volume":"209","author":"S Thavaneswaran","year":"2018","journal-title":"Med J Aust"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/cancers10020035","article-title":"Reviewing the Utility of EUS FNA to advance precision medicine in pancreatic cancer","volume":"10","author":"W Berry","year":"2018","journal-title":"Cancers"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.3748\/wjg.v29.i18.2864","article-title":"Endoscopic ultrasound-guided fine-needle aspiration pancreatic adenocarcinoma samples yield adequate DNA for next-generation sequencing: A cohort analysis","volume":"29","author":"S Bunduc","year":"2023","journal-title":"World J Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"5900","DOI":"10.1158\/1078-0432.CCR-21-1107","article-title":"Targeted transcriptome and KRAS mutation analysis improve the diagnostic performance of EUS-FNA Biopsies in pancreatic cancer","volume":"27","author":"J Lundy","year":"2021","journal-title":"Clin Cancer Res"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1002\/ijc.30648","article-title":"Endoscopic ultrasound-guided fine-needle aspirate-derived preclinical pancreatic cancer models reveal panitumumab sensitivity in KRAS wild-type tumors","volume":"140","author":"W Berry","year":"2017","journal-title":"Int J Cancer"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"335","DOI":"10.4103\/EUS-D-20-00230","article-title":"The EUS molecular evaluation of pancreatic cancer: A prospective multicenter cohort trial","volume":"10","author":"S Masoumi-Moghaddam","year":"2021","journal-title":"Endosc Ultrasound"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.1158\/1078-0432.CCR-22-3930","article-title":"Oncogenic drivers and therapeutic vulnerabilities in KRAS wild-type pancreatic cancer","volume":"29","author":"H Singh","year":"2023","journal-title":"Clin Cancer Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.1158\/1078-0432.CCR-18-0531","article-title":"Molecular profiling of patients with pancreatic cancer: Initial results from the Know Your Tumor Initiative","volume":"24","author":"MJ Pishvaian","year":"2018","journal-title":"Clin Cancer Res"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.1200\/PO.21.00437","article-title":"Exceptional response to olaparib and pembrolizumab for pancreatic adenocarcinoma with germline BRCA1 mutation and high tumor mutation burden: Case report and literature review","volume":"6","author":"J Lundy","year":"2022","journal-title":"JCO Precis Oncol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3390\/cancers16040761","article-title":"Endoscopic ultrasound-guided fine-needle biopsy versus aspiration for tissue sampling adequacy for molecular testing in pancreatic ductal adenocarcinoma","volume":"16","author":"WT Mohamed","year":"2024","journal-title":"Cancers"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s00535-023-02037-z","article-title":"Current status and issues in genomic analysis using EUS-FNA\/FNB specimens in hepatobiliary\u2013pancreatic cancers","volume":"58","author":"Y Ozono","year":"2023","journal-title":"J Gastroenterol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1158\/1078-0432.CCR-15-0426","article-title":"Precision medicine for advanced pancreas cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) trial","volume":"21","author":"LA Chantrill","year":"2015","journal-title":"Clin Cancer Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1158\/1078-0432.CCR-17-2994","article-title":"Genomics-driven precision medicine for advanced pancreatic cancer: early results from the COMPASS trial","volume":"24","author":"KL Aung","year":"2018","journal-title":"Clin Cancer Res"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/eus.0000000000000097","article-title":"Adequacy of EUS\u2013guided fine-needle aspiration and fine-needle biopsy for next-generation sequencing in pancreatic malignancies: A systematic review and meta-analysis","volume":"13","author":"Y Pan","year":"2024","journal-title":"Endosc Ultrasound"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1136\/gutjnl-2023-329495","article-title":"Standardisation of EUS-guided FNB technique for molecular profiling in pancreatic cancer: results of a randomised trial","volume":"72","author":"JY Bang","year":"2023","journal-title":"Gut"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.hpb.2023.07.900","article-title":"Diagnostic accuracy of endoscopic ultrasonography-guided tissue acquisition prior to resection of pancreatic carcinoma: a nationwide analysis","volume":"25","author":"R Quispel","year":"2023","journal-title":"HPB"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1038\/s41598-023-31579-8","article-title":"Characterization of pancreatic cancer with ultra-low tumor mutational burden","volume":"13","author":"T Imamura","year":"2023","journal-title":"Sci Rep"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3748\/wjg.v22.i2.801","article-title":"Noncoding RNAs and pancreatic cancer","volume":"22","author":"JF Peng","year":"2016","journal-title":"World J Gastroenterol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-021-00659-4","article-title":"The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives","volume":"6","author":"S Wang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1002\/1878-0261.13658","article-title":"Spliceosomic dysregulation in pancreatic cancer uncovers splicing factors PRPF8 and RBMX as novel candidate actionable targets","volume":"18","author":"E Alors-P\u00e9rez","year":"2024","journal-title":"Mol Oncol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2018-000469","article-title":"Prospective analysis of 895 patients on a UK Genomics Review Board","volume":"4","author":"DA Moore","year":"2019","journal-title":"ESMO Open"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S1470-2045(20)30074-7","article-title":"Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial","volume":"21","author":"MJ Pishvaian","year":"2020","journal-title":"Lancet Oncol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2023.100775","article-title":"The impact of the multi-disciplinary molecular tumour board and integrative next generation sequencing on clinical outcomes in advanced solid tumours","volume":"36","author":"A El Helali","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41379-018-0006-x","article-title":"Salvaging the supernatant: next generation cytopathology for solid tumor mutation profiling","volume":"31","author":"S Roy-Chowdhuri","year":"2018","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"360490","DOI":"10.1200\/JCO.2022.40.36_suppl.360490","article-title":"First data for sotorasib in patients with pancreatic cancer with KRAS p.G12C mutation: A phase I\/II study evaluating efficacy and safety","volume":"40","author":"JH Strickler","year":"2022","journal-title":"J Clin Oncol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e38196","article-title":"The road to overcome pancreatic cancer: Where are we?","volume":"10","author":"A Tirpe","year":"2024","journal-title":"Heliyon"}],"container-title":["Endoscopy International Open"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2733-1068.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T07:17:49Z","timestamp":1778224669000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2733-1068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":33,"journal-issue":{"issue":"CP","published-online":{"date-parts":[[2026,1,13]]},"published-print":{"date-parts":[[2026]]}},"alternative-id":["a27331068"],"URL":"https:\/\/doi.org\/10.1055\/a-2733-1068","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["2364-3722","2196-9736"],"issn-type":[{"value":"2364-3722","type":"print"},{"value":"2196-9736","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10,27]]},"published":{"date-parts":[[2025,10,27]]}}}